Shanghai, China

Minyu Luo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Minyu Luo: Innovator in Glycopeptide Compounds

Introduction

Minyu Luo is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of glycopeptide compounds that combat drug-resistant bacteria. His innovative work has the potential to address critical health challenges posed by antibiotic resistance.

Latest Patents

Minyu Luo holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent, titled "Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof," discloses compounds represented by a general formula. The invention provides a preparation method and application for these glycopeptide compounds. Testing has shown that these compounds have higher inhibition activity against drug-resistant strains, particularly MRSA and VRE, compared to the second-generation glycopeptide drug oritavancin. Furthermore, many of these compounds demonstrate safety profiles superior to oritavancin, making them suitable for developing drugs to treat various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.

Career Highlights

Minyu Luo has worked with notable companies in the biopharmaceutical sector, including Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Minyu Luo has collaborated with talented professionals, including Chang Shao and Mei Ge. These collaborations have fostered a productive environment for research and development in the field of biopharmaceuticals.

Conclusion

Minyu Luo's contributions to the development of glycopeptide compounds represent a significant advancement in the fight against drug-resistant bacteria. His innovative work and collaborations continue to pave the way for new therapeutic options in the biopharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…